Artificial intelligence is making waves across various industries, with healthcare standing to gain immensely from its advancements. Enter Harrison.ai, an Australian startup that has turned its innovative sights on radiology and pathology. Their latest contribution, Harrison.rad.1, aims to
The in vitro diagnostic (IVD) medical device market is on the cusp of transformative growth, driven by technological advancements, increased prevalence of chronic diseases, and a growing demand for early and accurate diagnostics. IVD devices, including reagents, test kits, and laboratory equipment,
Wisconsin is poised to revolutionize cancer treatment and the broader healthcare landscape through the establishment of a biohealth tech hub, supported by a significant $49 million federal investment. This ambitious initiative aims to spur innovations in personalized medicine and biohealth
In a significant development in the intersection of healthcare and technology, Roche is reportedly considering divesting Flatiron Health, a prominent cancer data startup it acquired for $1.9 billion in 2018. The acquisition was initially aimed at harnessing real-world evidence to propel
Flatiron Health, a pioneering oncology-focused health technology company, has joined forces with the Association of Cancer Care Centers (ACCC), a vast network of over 40,000 cancer care professionals, to revolutionize access to cancer clinical trials and empower healthcare providers through
The in vitro diagnostics (IVD) raw materials market is set to experience remarkable growth over the next decade, driven by technological advancements and increasing demands in healthcare. As the world's health needs evolve, this market, valued at USD 14,560 million in 2023, is anticipated to
